Indication intelligence, analysis and sector perception

RegMed Investors’ (RMi) closing bell; trading is very thin

April 23, 2018 4:56pm

The downside funnels the sector even lower

With 16 sessions of April’s closings (of 40 covered companies) having nine (9) negative, six (6) positive and one (1) neutral closes; today is the fourth (4^th ) losing streak in a row

The NASDAQ tanked (-0.25%) along with the IBB (-0.16%) and the Russell 2000 (RUT-0.13%)

Pre-open indication: 1 HIT

Research note: 1 HIT

As I had stated, “Speculation will be a thematic as those equities without news will hem and haw.”

End of day briefing; the “numbers” speak!

Henry’omics:

Today’s moves … Expectation left investors more than disappointed

The advance/decline line scenario of 40 covered companies:

The open was negative an A/DL to 12/23 and 5 flat;
The mid-day continued negative with an A/DL of 9/25 and 6 flats;
The close concluded negative with an A/DL of 7/28 and 5 flat;

From the pre-open’s newsletter, “… volatility has hurt as investors are frazzled by the sector’s downside trends with a byproduct of negativity; as usual after damning sessions, the oversold will hear the sirens song … to then be lured back to the bottom with even further damage to their pricing.”

As I had stated, “The sector is distinctly oversold yet few shining lights stand-out.

Every time one thinks being long is fruitful, they get hammered by the short-term impulses.

TOO MANY investors are losing faith in the hope of stem, cell and regenerative therapy companies.

Feathering the sector - lucky to be on the upside:

AGTC, ATHX – on news, CAPR, HSGX, IMUC, PSTI – on news, VCEL and VSTM with a range of highs of +$0.25 to $0.015 … the upside says it all for the sector!

Review the 16 sessions of April’s close (of 40 covered companies) there have been nine (9) negative and six (6) positive and one (1) neutral closes:

Monday closed NEGATIVE with 28 decliners, 7 advancers and 5 flat;
Friday closed NEGATIVE with 22 decliners, 12 advancers and 6 flat;
Thursday closed NEGATIVE with 28 decliners, 9 advancers and 3 flats;
Wednesday closed NEGATIVE with 24 decliners, 14 advancers and 2 flat;
Tuesday closed POSITIVE with 24 decliners, 15 advancers and 1 flat;
Monday closed NEGATIVE with 21 decliners, 14 advancers and 5 flats;
Friday closed barely NEGATIVE with 18 decliners, 17 advancers and 5 flats;
Thursday closed POSITIVE with 8 decliners, 30 advancers and 2 flats;
Wednesday closed NEUTRAL with 19 decliners, 19 advancers and 2 flats;
Tuesday closed POSITIVE with 7 decliners, 32 advancers and 1 flats;
Monday closed POSITIVE with 12 decliners, 23 advancers and 5 flats;
Friday closed NEGATIVE with 32 decliners, 7 advancers and 1 flats;
Thursday closed NEGATIVE with 25 decliners, 11 advancers and 4 flats;
Wednesday closed POSITIVE with 11 decliners, 28 advancers and 1 flat;
Last Tuesday closed POSITIVE with 19 decliners, 19 advancers and 2 flats;
The previous Monday closed NEGATIVE with 9 decliners, 31 advancers and 0 flats

MY working five (5) trend lines:

… The greatest volume to the downside: SGMO, NWBO, MDXG, BLCM and ADVM

… Upside volume was weighted to: XON, VSTM, ATHX, IMUC and VSTM

… Biggest $ downside: ONCE (-$3.46), RGNX (-$2.40), BLUE (-$2.25), AXGN (-$1.30) and QURE (-$1.14)

… Best moves to the $ upside: VCEL (+$0.25), VSTM (+$0.10), AGTC (+$0.10), ATHX (+$0.07) and XON (+$0.06)

… Flats: HSGX, ISCO, BSTG, ADRO and RENE.L

Daily analytics:

The Dow on Monday finished in negative territory for a fourth straight session, marking its longest losing trend since early March, as market’s wrestled with rising government bond yields.

The Dow closed off about 14 points, or less than 0.1%, at 24,448.
The S&P 500 index closed virtually unchanged at 2,670.
The NASDAQ finished the session down 0.3% at 7,128.

The CBOE Volatility Index (VIX) widely considered the best gauge of fear in the market,

Monday traded at 16.34, down -3.20% …
Friday traded at 16.88, up +5.76%
Thursday traded at 15.96, up +2.31%
Wednesday traded at 15.60, up +2.30%
Tuesday traded at 15.25, down -1.31%
Last Monday traded at 16.56, down -4.88%

The iShares Russell 2000 (IWM) indicated:

Monday was down -0.15%
Friday -0.54%
Thursday -0.69%
Wednesday +0.23%
Tuesday was up +1.08%
Last Monday +0.92%

The iShares NASDAQ Biotechnology (IBB) indication:

Monday was down -0.16%
Friday -0.88%
Thursday -1.36%
Wednesday +0.07%
Tuesday was up +1.94%
Last Monday -0.68%

The count - decliners versus gainers:

……. look at the differences in decliners:

Monday’s decliners ranged from -0.18% <FATE -$0.02 > to -6.05% <RGNX -$2.40 > in 28 equities;
Friday’s decliners ranged from -0.27% <FATE -$0.03 > to -13.89% <VTGN -$0.15 > in 22 equities;
Thursday’s decliners ranged from -0.18% <FATE -$0.02 > to -12.81% <NWBO -$0.026> in 28 equities;
Wednesday’s decliners ranged from -0.06% <CLLS -$0.02> to -10.96% <NWBO -$0.025 > in 24 equities;
Tuesday’s decliners ranged from -0.16% <MESO -$0.01 > to -12.60% < BLCM -$1.13> in 15 equities;
Last Monday’s decliners ranged from -0.11% <BLCM -$0.01> to -9.60% <SGMO -$1.90 > in 21 equities;

Versus

… Look at the percentage’s (%) and spreads …

Monday’s gainers ranged from +0.33% <XON +$0.06 > to +3.47% <ATHX +$0.07 > in 7 equities;
Friday’s gainers ranged from +0.28% <ONCE +$0.23> to +7.06% <NWBO +$0.0125> in 12 equities;
Thursday’s gainers ranged from +0.25% <VSTM +$0.01 > to +5.44% < OSIR +$0.40> in 9 equities;
Wednesday’s gainers ranged from +0.38% <BSTG (+$0.01 > to +14.01% <KOOL +$0.22 > in 14 equities;
Tuesday’s gainers ranged from +0.21% <CLBS +$0.01 > to +9.71% <ONVO +$0.10> in 24 equities;
Last Monday’s gainers ranged from +0.04% <NWBO +$0.00 > to +9.83% <RGNX +$3.40> in 14 equities;

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors. All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.

35 companies, 1 interpreter!

Insight, foresight and recommendation

What's Happening Today

9 hours 25 min ago
RegMed Investors’ (RMi) pre-open: head and knee down

My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.

My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.

Do you have an opinion you would like to share with us? We would like to hear from you.

Please e-mail us at hwm@regmedinvestors.com.

Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors with past experience in sell-side analysis, buy-side management, corporate management and due diligence.

RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.

The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.

The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.